United States 113th Congress Status: Died 1 R cosponsors

HRES 489 — Expressing the sense of Congress regarding the need to facilitate and promote a robust response to the looming global crisis of Alzheimer's and other forms of dementia.

Last action — Referred to the Subcommittee on Health.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 113th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

States that it should be the policy of the U.S. government to encourage and facilitate the following efforts concerning Alzheimer's disease and other forms of dementia: entry by the Secretary of Health and Human Services (HHS) into negotiations with the World Health Organization to develop a Global Alzheimer's and Dementia Action Plan; involvement of all other nations that have adopted national Alzheimer's and/or dementia plans or strategies; development of the foundation for a Global Alzheimer's Fund that would provide resources to support implementation of specific strategies of the Global Plan and assignment of a high-level person to lead and coordinate initiatives; investigation by the G8 nations of systems to monitor and provide care to persons with Alzheimer's and other forms of dementia in developing countries to help build care delivery capacity; investigation by the U.S. Agency for International Development (USAID) of the foreign aid implications of Alzheimer's and other forms of dementia and inform Congress of the need for possible changes to health care-related foreign assistance; and encouragement and facilitation of partnerships with the private sector, such as the current partnership between the National Institutes of Health (NIH) and 10 pharmaceutical companies to identify new approaches to treat Alzheimer's and other medical conditions.

Bill Text

We don't have the full text on file for this bill yet.

Read HRES 489 on the official United States source →

Action History

  1. Referred to the Subcommittee on Health.

  2. Referred to House Energy and Commerce

  3. Referred to House Foreign Affairs

  4. Referred to the Committee on Foreign Affairs, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HRES 489 do?
States that it should be the policy of the U.S. government to encourage and facilitate the following efforts concerning Alzheimer's disease and other forms of dementia: entry by the Secretary of Health and Human Services (HHS) into negotiations with the World Health Organization to develop a Global Alzheimer's and Dementia Action Plan; involvement of all other nations that have adopted national Alzheimer's and/or dementia plans or strategies; development of the foundation for a Global Alzheimer's Fund that would provide resources to support implementation of specific strategies of the Global Plan and assignment of a high-level person to lead and coordinate initiatives; investigation by the G8 nations of systems to monitor and provide care to persons with Alzheimer's and other forms of dementia in developing countries to help build care delivery capacity; investigation by the U.S. Agency for International Development (USAID) of the foreign aid implications of Alzheimer's and other forms of dementia and inform Congress of the need for possible changes to health care-related foreign assistance; and encouragement and facilitation of partnerships with the private sector, such as the current partnership between the National Institutes of Health (NIH) and 10 pharmaceutical companies to identify new approaches to treat Alzheimer's and other medical conditions.
Who sponsors HRES 489?
HRES 489 is sponsored by Christopher Smith (R).
What is the current status of HRES 489?
This bill died with 113th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HRES 489?
Track HRES 489 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HRES 489

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HRES 489

Last checked for changes about 11 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →